Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

THC Biomed Intl Ltd. (C:THC)

Business Focus: Alternative Medicine

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for THC within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Jan 28, 2020 07:30 ET
THC BioMed Intl Ltd. Turns a Profit as Revenue Breaks $1 Million -- CFN Media
Seattle, Washington--(Newsfile Corp. - January 28, 2020) - CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article taking a closer look at THC BioMed Intl Ltd.'s (CSE: THC) (OTCQX: THCBF) ("THC BioMed") strong quarterly performance and what catalysts investors can look forward to ahead.
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
2.17
--
--
Price to Sales - TTM
10.26
11.84
10.56
Price to Book - most recent quarter
1.53
1.37
2.07
Price to Cash Flow per share - TTM
--
4.82
12.29
Price to Free Cash Flow per share - TTM
--
1.40
18.54
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Feb 15, 202020,087-175,417
Jan 31, 2020195,504165,377
Jan 15, 202030,127-2,090
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

THC BioMed Intl Ltd. is a development-stage company. The Company is engaged in the business of scientific research and development, and cultivation of medical marijuana in Canada. The Company produces medical marijuana, cannabis oil and cannabis resin. The Company intends to cultivate medical marijuana and conduct scientific research and development in order to offer products and services through two revenue streams: medical marijuana sales to other Marihuana for Medical Purposes Regulations (MMPR) licensed producers, and products and services related to medical marijuana. It provides a range of services, including consulting, quality assurance training, horticulture training, simulated inspections, record keeping/documenting, physical security plans and analytical services. Its consulting service assists in finding solutions to MMPR related questions. Its horticulture training service provides education in botany basics, plant identification, soil science and nursery techniques.

See business summary

Twitter

Search (past week) for $THC.CA

  • No tweets found